US pharmaceutical stocks
The US pharmaceutical sector is made up of players that include drug manufacturers, drug marketers, and biotechnology companies.
Some of the pharmaceutical stocks that have surpassed the returns of the S&P 500 Index YTD (year-to-date) include Eli Lilly and Company (LLY), Pfizer (PFE), Merck & Co. (MRK), Allergan (AGN), and GlaxoSmithKline (GSK).
The chart above compares the normalized stock prices of these companies to the S&P 500 Index.
S&P 500’s performance
The S&P 500 Index has reported a rise of ~8.6% YTD. The index’s closing price was $2,904.18 on September 13.
Eli Lilly has reported a ~26.2% rise in its stock price YTD. The closing price for Eli Lilly stock was $106.58 on September 13.
Pfizer has reported an ~18.3% rise in its stock price YTD. The closing price for Pfizer stock was $42.85 on September 13.
Merck & Co. has reported a ~25.9% rise in its stock price YTD. The closing price for Merck & Co. stock was $70.83 on September 13.
Allergan has reported a ~16.2% rise in its stock price YTD. The closing price for Allergan stock was $190.08 on September 13.
GlaxoSmithKline’s ADR (American depositary receipt) has reported a ~10.8% rise YTD. The closing price for GlaxoSmithKline was $39.33 on September 13.
The SPDR S&P 500 ETF (SPY) has reported a ~9.0% rise YTD. SPY holds 0.4% of its total investments in Eli Lilly, 1.0% in Pfizer, 0.8% in Merck & Co., and 0.3% in Allergan.